GlaxoSmithKline plc (GSK) Reports Q4 EPS of GBP0.22

GlaxoSmithKline plc (NYSE: GSK) reported Q4 EPS of GBP0.22, versus GBP0.51 reported last year. Revenue for the quarter came in at GBP6.19 million, versus GBP6.91 million reported last year.

For earnings history and earnings-related data on GlaxoSmithKline plc (GSK) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss